バンクーバー, BC

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated financial results for the fourth quarter and fiscal year ended September 30, 2021.

EnWave’s vacuum-microwave machine and royalty business performed materially better in fiscal 2021 than in fiscal 2020, with record margins and profitability.

NutraDried, the Company’s wholly-owned subsidiary, struggled during the first two fiscal quarters leading to a material restructuring that positively improved results in Q3 and Q4. The turnaround at NutraDried is well underway with new leadership and there are material opportunities to further improve the performance of this business unit in fiscal 2022.

連結業績：

* Adjusted EBITDA is a non-IFRS financial measure. Refer to the disclosure below and in the Company’s MD&A regarding non-IFRS financial measures.

エンウェーブの年次連結財務諸表およびMD&Aは、SEDAR（www.sedar.com）および当社ウェブサイト（www.enwave.net）でご覧いただけます。

Key Financial Highlights for Q4 (expressed in ‘000s):

• The Company reported consolidated revenue for Q4 2021 of $6,906 compared to $7,351 in Q3 2021 and $10,784 in Q4 2020.
  • EnWave’s Q4 2021 business unit revenue was $3,879 compared to $1,601 in Q4 2020, an increase of $2,278. EnWave ramped revenues from Radiant Energy Vacuum (“REV^™”) machine sales with current and new licensees for the food and cannabis industries.
  • NutraDried’s Q4 2021 revenue was $3,027 compared to $9,183 for Q4 2020, a decrease of $6,156 largely due to the elimination of a large national buy-one, get-one Costco promotion shipped in Q4 2020. NutraDried continues to rebuild distribution for its Moon Cheese^® product portfolio and subsequently has confirmed new Costco shipments scheduled in Q1 and Q2 2022 on both Canada and the U.S.
• Gross margin for Q4 2021 was 34% compared to 20% for Q4 2020, a major increase due to the confirmation of higher margin REV™ machine sales during the period. Gross margin in Q3 2021 was 36%, and the 34% achieved in this quarter was broadly consistent with a strong margin profile. Throughout 2021, EnWave successfully redeployed three large-scale REV™ machines that were not being utilized from two Canadian cannabis partners, generating robust margins in its machine sales business.
• Adjusted EBITDA^(*), a non-IFRS financial measure, for Q4 2021 was a loss of $223 compared to Adjusted EBITDA^(*) of $20 for Q4 2020 and Adjusted EBITDA^(*) of $937 for Q3 2021. The Adjusted EBITDA^(*) for Q4 2021 was near to break-even, and the Company remains focused on further market penetration at EnWave and NutraDried in pursuit of consistent, growing profitability. The Company made significant progress towards this target since the restructuring and cost control program implemented at NutraDried in Q2 2021.
• EnWave purchased and cancelled 1,572,900 common shares in Q4 under the Normal Course Issuer Bid at an average share price of $1.01 using cash of $1,597.
• 2021年10月29日から2022年10月28日までの間、エンウエイブは30日間に2,204,101株を上限として、年間10,778,194株を購入することができる。

Significant Corporate Accomplishments in Q4 2021:

• Signed a royalty-bearing commercial license agreement and sold a 10kW GMP REV™ machine to Cannaponics PTY Limited, an Australian cannabis company.
• Advanced the development of using REV™ in the pharmaceutical sector through a material transfer agreement with AstraZeneca AB (NASDAQ:AZN) to dry monoclonal antibodies and completed the installation of a pilot-scale pharmaceutical REV™ machine with GEA Lyophil GmbH (“GEA”). EnWave has a joint development agreement with GEA in place to advance the design and application of microwave-assisted lyophilization for pharmaceutical applications, and the pilot-scale machine will be used to conduct demonstrations for interested pharmaceutical companies. GEA has several leading global pharmaceutical companies confirmed to trial REV™ in 2022.
• Completed the commissioning of a third 10kW REV™ machine for the U.S. Army at its third-party manufacturing partner’s facility, Bridgford Foods Corporation (NASDAQ: BRID). The machine will be used by Bridgford Foods to produce Close Combat Assault Rations for field testing under the U.S. Army’s development program.
• Signed a royalty-bearing commercial license agreement and sold a 10kW GMP REV™ to Medical Kiwi Limited, a New Zealand cannabis company.
• Signed a royalty-bearing commercial license agreement with a leading Colombian dairy company and sold a 10kW machine for installation in Colombia to conduct initial commercial market trials. If initial efforts are successful, the Colombian dairy company will require additional REV™ machinery to scale for meaningful commercial production.
• Formed a global strategic partnership with Dole Worldwide Food & Beverages Group for the use of REV™ technology to produce Innovative Nutrition Solutions. Dole purchased a 10kW REV™ machine to conduct intensive market trials. The strategic partnership with Dole will leverage EnWave’s REV™ technology to bring better-for-you snacking options to its global customer base under its industry-leading brand. Concurrent in its snack product development, EnWave and Dole are collaborating on the development of superior functional ingredients that use upcycled fruit materials.
• Signed a royalty-bearing commercial license agreement and sold a 10kW GMP REV™ to a second Australian cannabis company.
• Developed extensive cannabis drying protocols using the Company’s proprietary Terpene Max™ rapid drying protocol and collected empirical data supporting both the quality and processing advantages for EnWave’s technology in the cannabis industry. Results from controlled studies show that cannabis flower dried using TerpeneMax™ on average contains 10-20% more terpenes than room or rack dried flower, and in many instances contained higher THC content than the control samples.
• Signed a royalty-bearing commercial license agreement with one of the largest American multi-state operators (the “MSO”). The MSO conducted extensive diligence over the advantages of using REV™ for the rapid and controlled drying of cannabis for both combustible and extract products and purchased a 120kW REV™ system to commence commercial operations using the technology.
• Added three new sales channel representatives to advance the sales, marketing and licensing of REV™ machinery into the European and Latin American markets.

Significant Corporate Accomplishments Subsequent to Q4 2021:

• Commissioned a 120kW REV™ machine for the large-scale processing of premium smokable cannabis for the Illinois-based cannabis partner. This now provides the second in-market use-case for the value-added processing of cannabis using the Company’s proprietary TerpeneMax™ drying protocol. EnWave anticipates generating the royalties from the partner’s use of the technology in Q1 2022.
• スペインのPatatas Fritas Torres社（以下「Torres社」）に100kWのREV™マシンを委託し、ヨーロッパ市場向けのオールナチュラルチーズスナックの商業的発売をスケールアップ。トーレスは、EnWave技術を使用した「Just This」チーズスナックブランドを立ち上げました（justthis-snacks.com/en/）。
• Secured a national promotion for 10oz Gouda Moon Cheese^® with Costco Canada that is expected to ship in late Q1 and into early Q2 2022. Confirmed an additional rotation for Moon Cheese^® with a U.S. region of Costco for Q2 2022. NutraDried will continue to pursue Costco as a strategic customer for the club channel while aggressively pursuing growth in the U.S. grocery channel and in bulk sales.
• アイルランドのDairy Concepts IRL社に2台目の10kW REV™機を販売し、同社のラインアップであるCheese O's保存用チーズスナックの製造規模を拡大。
• プロテイン・アイソレート・プラント・インターナショナル社（「PIPインターナショナル社」）と技術評価契約を締結し、PIPインターナショナル社の大規模イエローエンドウ湿式分画処理施設におけるREV™技術の商業利用の可能性を評価。
• Entered India, a major new market for REV™ production, by signing a Technology Evaluation and License Option Agreement with M/S Lalsai Dehy Foods (“LD Food”) and placing a 10kW REV™ machine under rental with LD Food for extensive product development on agricultural products for the Indian market.
• Advanced a new product launch opportunity at NutraDried in preparation for a Spring 2022 launch intended to strengthen NutraDried’s competitive advantage as a category innovator in the rapidly growing healthy snack space. NutraDried plans to explore, and when appropriate, launch innovative and exciting new products to leverage the use of REV™ in the better-for-you snack vertical.

EnWave’s executive management will be holding a conference call to discuss its 2021 Fourth Quarter and 2021 Annual Financial Results and the Company’s state of affairs.  Prepared remarks will be given followed by a question-and-answer session for shareholders.

電話会議

EnWave’s executive management will be holding a conference call to discuss its 2021 Fourth Quarter and 2021 Annual Financial Results and the Company’s state of affairs.  Prepared remarks will be given followed by a question-and-answer session for shareholders.

Date: December 16, 2021

Time: 7:00am PST / 10:00am EST

Participant Access: 1-877-407-2988 (toll-free number)

Webcast: https://78449.themediaframe.com/dataconf/productusers/enw/mediaframe/47460/indexl.html

^(*) Non-IFRS Financial Measures:

Adjusted EBITDA is not a measure of financial performance under IFRS. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring and severance charges and government assistance. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the discussion included in the Company’s annual MD&A for the year-ended September 30, 2021 for a reconciliation from net loss to Adjusted EBITDA.

アップデートのダウンロードはこちら

エンウェーブについて

バンクーバーを拠点とする先端技術企業、エンウェーブ・コーポレーションは、有機物を正確に脱水する革新的な独自手法であるラジアント・エナジー・バキューム（「REV™」）を開発した。EnWave社はさらに、REV™技術を使って大麻を均一に乾燥・除染する特許取得済みの方法を開発し、収穫から大麻製品が市場に出回るまでの時間を短縮しました。

REV™技術の商業的可能性は実証されており、合法的な大麻を含む食品、医薬品分野の複数の市場垂直方向で急速に成長しています。エンウェーブの戦略は、REV™技術の使用に関して、複数の垂直市場において革新的で破壊的な企業とロイヤリティを伴う商業ライセンスを締結することです。現在までに30件以上のロイヤリティ付きライセンスを締結している。これらのライセンスに加え、エンウェーブは有限責任会社NutraDried Food Company, LLCを設立し、Moon^Cheese®ブランドを含む米国内の天然乳製品スナック製品の製造、マーケティング、販売を行っている。

エンウェーブは、凍結乾燥よりも迅速かつ低コストで、風乾や噴霧乾燥よりも優れた最終製品品質を実現するREV™を、食品および生物材料の分野における新たな脱水標準として導入しました。
1.nutraREV®は、栄養、味、食感、色を高いレベルで維持しながら、食品を迅速かつ低コストで乾燥させるために食品産業で使用されています。
2.quantaREV®は、連続的な大量低温乾燥に使用されています。

エンウェーブの詳細については、www.enwave.net をご覧ください。

エンウェーブ・コーポレーション
ブレント・チャールトン、CFA
社長兼CEO

詳細はこちら：

Brent Charleton, CFA
社長兼 CEO 電話: +1 (778) 378-9616
E-mail:bcharleton@enwave.net

Dan Henriques, CA, CPA,
最高財務責任者 電話: +1 (604) 835-5212
E-mail:dhenriques@enwave.net

メディアからのお問い合わせ：
Eメール：media@enwave.net

将来予測情報に関する記述のセーフハーバー：本プレスリリースには、経営陣の期待、見積もり、予測に基づく将来の見通しに関する情報が含まれている場合があります。当社の成長戦略、製品開発、市場での地位、予想される支出、クロージング後に期待されるシナジー効果に関する記述を含め、将来に対する期待や予測に言及する記述はすべて、将来の見通しに関する記述です。本リリースで言及されている第三者の主張はすべて、その正確性を保証するものではありません。本リリースに記載されている市場情報に関する第三者の言及はすべて、当社が独自に一次調査を行ったものではないため、正確性を保証するものではありません。これらの記述は将来の業績を保証するものではなく、多くのリスク、不確実性および仮定を含んでいます。当社は、実際の結果と大きく異なる可能性のある重要な要因を特定するよう努めましたが、予想、見積りまたは意図したとおりの結果とならないその他の要因が存在する可能性があります。実際の結果や将来の事象は、かかる記述で予想されたものとは大きく異なる可能性があるため、かかる記述が正確であることを保証するものではありません。したがって、読者は将来の見通しに関する記述を過度に信頼すべきではありません。

TSXベンチャー取引所およびその規制サービスプロバイダー（この用語はTSXベンチャー取引所の方針で定義されています）は、本リリースの妥当性または正確性について責任を負いません。